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Bladder cancer is the fourth most common cancer in men and the 
tenth most common in women, and while long-term survival is 
more predominant compared to other common cancers, more than 
47% percent of bladder cancer deaths could have been avoided 
with an early diagnosis (Verma et al., http://dx.doi.org/10.1148/
rg.322115125). Initial diagnosis is generally made via cystoscopy, 
but magnetic resonance imaging (MRI) can be considered superior 
due to higher soft-tissue contrast that can detect small tumors 
and increased accuracy in determining the extent of muscle 
invasion. The Thompson Group has used fi bronectin attachment 
protein (FAP) to target liposomes to bladder tumor cells. 
To expound upon this previous work, we designed a synthetic 
pathway for a peptide-targeted MRI contrast agent and have made 
signifi cant progress toward the fi nal construct, which is composed 
of HP-β-CD threaded onto a polymer core and further modifi ed 
with Gd-DOTA and a maleimide linker to attach the FAP peptide.
This type of construct is called a polyrotaxane (PR), and we have 
shown that PRs whose CDs have been modifi ed with Gd-DOTA 
have a high relaxivity and extended contrast in various organs. 
New preparation and attachment methods for the maleimide linker 
are under investigation, as is the most effective coupling method 
for the FAP peptide. Subsequent studies will include cell culture, 
relaxivity measurements, and in vivo MR imaging with mice to 
determine the agent’s targeting and contrast enhancement abilities.
Research advisor Bradley Loren writes: “I have been lucky to have 
had the opportunity to work with Cheyenne for the last two years. 
She always strives to excel at everything she does, and I know 
she will continue to do great things as a graduate student at the 
University of Pennsylvania next year.”
 STEM
A cartoon depiction of polyrotaxane formation. Hydroxypropyl-
β-cyclodextrin units are threaded onto the polymer core akin to 
beads being threaded onto a string, followed by an endcapping 
reaction to prevent dethreading. The polyrotaxane is further 
modi ed with Gd-DOTA and the targeting FAP peptide to 
produce the MR contrast agent. 
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